Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Net Asset Momentum
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) recorded a net asset momentum of -3.0% as of December 2024, with net assets of CN¥1.89 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check tangible net worth ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Suzhou Fushilai Pharmaceutical Co. Ltd. Net Asset Momentum (2019–2024)
This chart tracks Suzhou Fushilai Pharmaceutical Co. Ltd.'s year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -3.0%, with net assets of CN¥1.89 Billion CNY as of December 2024. Read 301258 total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
The table below shows the complete annual net asset history for Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) total market value.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.89 Billion | CN¥2.09 Billion | CN¥200.84 Million | ▼ -3.0% |
| 2023 | CN¥1.95 Billion | CN¥2.12 Billion | CN¥170.45 Million | ▲ +3.1% |
| 2022 | CN¥1.89 Billion | CN¥2.10 Billion | CN¥211.75 Million | ▲ +154.0% |
| 2021 | CN¥742.84 Million | CN¥970.31 Million | CN¥227.47 Million | ▲ +19.3% |
| 2020 | CN¥622.64 Million | CN¥788.25 Million | CN¥165.61 Million | ▲ +7.0% |
| 2019 | CN¥581.96 Million | CN¥751.44 Million | CN¥169.48 Million | — |